![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 09, 2010 2:51:06 PM
From their last 10Q ( http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6974288 )on page 14 and 15:
Plan of Operation
The Company plans on becoming a significant transdisciplinary biomedical/biotechnology company involved in the discovery, development, acquisition and commercialization of a broad range of biotechnology, and biomedical technologies as well as nutraceutical and molecular diagnostic technologies to improve human health.
We intend to develop, manufacture and sell directly or indirectly through collaborative partners, the following types of products:
PRODUCT/R&D PHASE/DESCRIPTION
VivaThermic Vials / Phase III / Centrifugable and autoclavable vials for cryopreservation
Cryopsy / Phase I / Device that rapidly freezes tissue specimens
VivaSight / Phase II / Digital PhotoRefractor for children's vision screening
VivAuris / Phase II / nDevice for middle ear redness detection
VivaGlobin / Phase II / Device for anemia and Cutaneous hemoglobin detection
VivaBoost / Phase III / Phytochemical rich daily dose nutraceutical beverage
VivaBlend / Phase III / Concentrated phytochemical/ antioxidant extract supplement
VivaGastroProtect / Phase I / Fruits and vegetables extract for the protection of digestive system
VivaCrop /Phase I / Vegetation health monitor
Clinical Sensor (CBS)/ Phase I / In vitro diagnostic device used at the point of care
SLICES / Phase II /MRI enhancement software
We also plan to continue to offer contract research and development services in molecular biology, device engineering and other areas. We commenced providing contract research and development services in the first quarter of 2008. During the first quarter 2009, we commenced sales of our VivaThermic vials and we commenced sales of VivaBlend in the second quarter of 2009. In December 2009, we entered into a license agreement with Regeneca International, Inc. (“Regeneca”) for VivaBoost whereby Regeneca obtained exclusive worldwide distribution rights in the direct-to-consumer market and has committed to purchase $5,000,000 of product over a thirty-six month period. ....
Looks like they have a lot of products in the development phase. in other way VIVK remind me MMRF who had a lot of positive news and was flat at 0.06 for lot of time(Link to 1 year chart http://stockcharts.com/h-sc/ui?s=MMRF&p=D&yr=1&mn=0&dy=0&id=p27722707303 )
Good luck
Loonley Tunes
Before you buy something do a good DD and make your own conclusions. My post express only my oppinion.
Recent VIVK News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/18/2024 09:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 01:45:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 09:28:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:25:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 12:41:40 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/23/2024 01:25:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 09:29:33 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:06:58 PM
- Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm • PR Newswire (US) • 03/15/2024 04:53:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:24 PM
- Socially Responsible Energy Operator Announces Planned Acquisition, Sending Shares Higher • AllPennyStocks.com • 03/04/2024 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:10:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 10:17:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/09/2024 10:11:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:44:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:30:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/12/2023 10:26:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:45:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/24/2023 10:10:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:30:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:41:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/17/2023 04:20:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:10 PM
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM